INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design

Clinical trial NCT03467425 · COMPLETED

Trial details

NCT number: NCT03467425
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2018-04-11
Primary completion: 2019-10-10
Enrollment: 3109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.